Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RPS19P3, or ribosomal protein S19 pseudogene 3, is a processed pseudogene located in the human genome. It shares high sequence identity with the functional RPS19 gene, which encodes a component of the small 40S ribosomal subunit involved in protein synthesis[2][6]. Unlike RPS19, RPS19P3 does not encode a functional protein and has no established roles in biochemistry, disease, or therapeutics. Pseudogenes like RPS19P3 may arise from duplication events or reverse transcription, but typically do not produce stable or functional proteins. There is no evidence that RPS19P3 serves as a therapeutic target or biomarker, and it is not involved in known biological functions or diseases[2][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S19 pseudogene 3 (RPS19P3).